Company News & Press

Media, Press, and other Proxima Company Updates

2022 Forecast: Adapting to Change In Today's Medical Developments

Proxima Clinical Research Honored by AVA Digital Awards

Kevin Coker: How To Avoid Alienating Your Loyal Customers During A Rebrand

Proxima CRO's Client, AMF Medical Received Breakthrough Device Designation For Sigi™ Insulin Management System

Kevin Coker: Are Tall Tales Detracting Investors?

Newsletter: New Year, New Pills | January 5th, 2022

Kevin Coker: Three Tips For New Entrepreneurs To Build Investor Excitement Without Lying

Newsletter: Hi-Tech, Humblebrags, and Hype Unraveled | December 20th, 2021

Newsletter: Curing the Common Cold with Cows | December 6th, 2021

Newsletter: Prosecution Rests, Patient Zero & Pre-Turkey Plans | November 22nd, 2021

Proxima Clinical Research: NW Diamond Notes Medical Device And Diagnostic Contract Market 2021

Proxima Clinical Research Among Elite Organizations Receiving High Honors From MarCom Awards

Proxima Newsletter

Rants, raves and observations.
Occasionally an opinion or fact.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Expertise

Resources

Company

Company Updates

Connect

2450 Holcombe Blvd.
Houston, TX 77021

Hello@ProximaCRO.com
+1.936.463.2221‬

Proxima Clinical Research, Inc. (aka Proxima CRO) is a registered Delaware C Corp, headquartered in Houston, TX
© Copyright 2024 Proxima Clinical Research, Inc. All Rights Reserved.